KT-621 clinical trials

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

This study is testing a new medicine, KT-621, for adults with moderate to severe eosinophilic asthma. We want to see if it's safe, how well it works, and how it acts in the body.